NEUROBO PHARMACEUTICALS INC's ticker is and the CUSIP is 64132R206. A total of 9 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,130 | – | 19,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BNP PARIBAS FINANCIAL MARKETS | 38 | $520,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 8 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3 | $0 | 0.00% |
| MORGAN STANLEY | 2 | $0 | 0.00% |
| BlackRock Inc. | 707 | $9,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 178 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 11,393 | $156,000 | 0.00% |
| UBS Group AG | 3,765 | $52,000 | 0.00% |